Cart 1 Product Products 384,00 € (empty)
No products
To be determined Shipping
384,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 1 items in your cart. There is 1 item in your cart.
Total products (tax excl.) 384,00 €
Total shipping (tax excl.) To be determined
Total (tax excl.) 384,00 €
Data sheet of PRDX1 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Rabbit |
| Applications | WB-Ce |
More info about PRDX1 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB1218 |
| Product name: | PRDX1 polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against full length recombinant PRDX1. |
| Gene id: | 5052 |
| Gene name: | PRDX1 |
| Gene alias: | MSP23|NKEFA|PAG|PAGA|PAGB|PRX1|PRXI|TDPX2 |
| Gene description: | peroxiredoxin 1 |
| Immunogen: | Recombinant protein corresponding to full length human PRDX1. |
| Form: | Liquid |
| Recommend dilutions: | Western Blot (1:1800) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In HEPES, 150 mM NaCl (50% glycerol, 0.01% BSA, 0.03% sodium azide) |
| Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | Immunoblot analysis of cell lysates. Lane 1 : HeLa cell lysate. Lane 2 : A-431 cell lysate. * For Western blots, incubate membrane with diluted antibody in 5% w/v BSA , 1X TBS , 0.1% Tween-20 at 4°C with gentle shaking , overnight. |
| Applications: | WB-Ce |
| Shipping condition: | Dry Ice |
| Publications: | Structure, mechanism and regulation of peroxiredoxins.Wood ZA, Schroder E, Robin Harris J, Poole LB. Trends Biochem Sci. 2003 Jan;28(1):32-40. |